Liso-Cel Maintains Longer-Term Responses in Pretreated Relapsed/Refractory CLL/SLL

Tatyana Feldman, MD, highlights updated data for liso-cel in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Related Keywords

Hackensack ,New Jersey ,United States ,Tatyana Feldman ,Transcend ,John Theurer Cancer Center ,D ,Iso Cel ,Car T ,Cll ,Relapsed Refractory Chronic Lymphocytic Leukemia Small Lymphoma ,Phase 1 2 Transcend Cll 004 Trial Nct03331198 ,